Health-related quality of life measured using the EQ-5D-5L: South Australian population norms

Health and Quality of Life Outcomes

Volumn 14, Issue 1, 2016, Pages

  McCaffrey, Nikki ^a   Kaambwa, Billingsley ^a   Currow, David C ^a   Ratcliffe, Julie ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

EQ 5D; Population norms; Quality of life; Utility

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EQ 5D 5L; FEMALE; GENERAL HEALTH STATUS ASSESSMENT; HEALTH STATUS; HEALTH SURVEY; HUMAN; INCOME; MALE; MARRIAGE; MIDDLE AGED; OBSERVATIONAL STUDY; POPULATION RESEARCH; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SEX DIFFERENCE; SOCIAL NORM; SOUTH AUSTRALIA; VISUAL ANALOG SCALE; AGE; COMPARATIVE STUDY; DEVICES; PSYCHOMETRY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTH AUSTRALIA;

EID: 84988492495     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-016-0537-0     Document Type: Article

References (66)

1. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines--similarities, differences and some implications. Value Health. 2001;4:225-50.
2. Sullivan SM, Wells G, Coyle D. What guidance are economists given on How to present economic evaluations for policymakers? A systematic review. Value Health. 2015;18:915-24.
3. Merlo G, Page K, Ratcliffe J, Halton K, Graves N. Bridging the Gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Applied Health Economics and Health Policy. 2015;13:303-9.
4. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford, UK: Oxford University Press; 2005.
5. Brazier J, Ratcliffe J, Tsuchiya A, Salomon J. Measuring and Valuing Health Benefits for Economic Evaluation. 2nd ed. Oxford: Oxford University Press; 2016. in press.
6. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727-36.
7. Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health and Quality of Life Outcomes. 2015;13:1-16.
8. Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes. 2014;12:74.
9. Craig BM, Pickard AS, Lubetkin EI. Health problems are more common, but less severe when measured using newer EQ-5D versions. J Clin Epidemiol. 2014;67:93.
10. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717-27.
11. Garcia-Gordillo MA, Adsuar JC, Olivares PR. Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011. Qual Life Res. 2015.
12. Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Office of Health Economics: London, UK; 2016.
13. Ravens-Sieberer U. Measuring and monitoring quality-of-life in population surveys: still a challenge for public health research. Soz Praventivmed. 2002;47:203-4.
14. Kularatna S, Whitty JA, Johnson NW, Jayasinghe R, Scuffham PA. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka. PLoS One. 2014;9:e108434.
15. Banham D, Hawthorne G, Goldney R, Ratcliffe J. Health-related quality of life (HRQoL) changes in South Australia: comparison of burden of disease morbidity and survey-based health utility estimates. Health Qual Life Outcomes. 2014;12:113.
16. Health Quality Council of Alberta. 2014 Alberta population norms for EQ-5D-5L. Alberta, Canada: Health Quality Council of Alberta; 2014. p. 104.
17. Hinz A, Kohlmann T, Stobel-Richter Y, Zenger M, Brahler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23:443-7.
18. Scalone L, Cortesi PA, Ciampichini R, Cesana G, LG M. Health related quality of life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiology, biostatistics and public health. 2015;12:e11457 11451-11415.
19. Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2015;25:707-19.
20. Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci 2015:1-10.
21. Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernandez G, Morales M, Gibbons L, Ramos-Goni JM. An EQ-5D-5L value set based on Uruguayan population preferences. Qual Life Res. 2016;25:323-33.
22. Clemens S, Begum N, Harper C, Whitty J, Scuffham P. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res. 2014;23:2375-81.
23. Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47:255-61.
24. Johnson JA, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care. 2000;38:115.
25. Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, Burström K. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res. 2011;20:309-20.
26. Sorensen J, Davidsen M, Gudex C, Pedersen KM, Bronnum-Hansen H. Danish EQ-5D population norms. Scand J Public Health. 2009;37:467-74.
27. Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, Lonnqvist J. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res. 2006;15:1403-14.
28. Golicki D, Niewada M. General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland. Pol Arch Med Wewn. 2015;125:18-26.
29. Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population norms. Qual Life Res. 2014;23:425-30.
30. Abdin E, Subramaniam M, Vaingankar J, Luo N, Chong S. Population norms for the EQ-5D index scores using Singapore preference weights. Qual Life Res. 2015;24:1545-53.
31. Burström K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-Å, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23:431-42.
32. Perneger TV, Combescure C, Courvoisier DS. General population reference values for the French version of the EuroQol EQ-5D health utility instrument. Value Health. 2010;13:631-5.
33. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736-41.
34. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078.
35. Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) Instrument in a Greek General Population. Value Health. 2008;11:1162-9.
36. Billa G, Thakkar K, Jaiswar S, Dhodi D. A cross-sectional study to evaluate the awareness and attitudes of physicians towards reducing the cost of prescription drugs, Mumbai. Applied Health Economics and Health Policy. 2014;12:125-37.
37. Phillips J, Dal Grande E, Ritchie C, Abernethy AP, Currow DC. A population-based cross-sectional study that defined normative population data for the life-space mobility assessment-composite score. J Pain Symptom Manag. 2015;49:885-93.
38. Currow DC, Burns C, Agar M, Phillips J, McCaffrey N, Abernethy AP. Palliative caregivers Who would Not take on the caring role again. J Pain Symptom Manag. 2011;41:661-72.
39. Oppe M, Devlin NJ, van Hout B, Krabbe PFM, de Charro F. A program of methodological research to arrive at the New international EQ-5D-5L valuation protocol. Value Health. 2014;17:445-53.
40. StataCorp. Stata statistical software: release 13. In: StataCorp LP. Texas, USA: College Station; 2013.
41. Wilson D, Wakefield M, Taylor A. The South Australian health omnibus survey. Health Promotion Journal of Australia. 1992;2:47-9.
42. Sun S, Chen J, Kind P, Xu L, Zhang Y, Burström K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24:693-703.
43. Szende A, Williams A. Measuring Self-Reported Population Health: An International Perspective based on EQ-5D. Euroqol Group: Rotterdam; 2004.
44. Hawthorne G, Korn S, Richardson J. Population norms for the AQoL derived from the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Public Health. 2013;37:7-16.
45. Hawthorne G, Osborne R. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health. 2005;29:136-42.
46. Norman R, Church J, van den Berg B, Goodall S. Australian health-related quality of life population norms derived from the SF-6D. Aust N Z J Public Health. 2013;37:17-23.
47. Cohen J. The Significance of a product moment rs. In: Cohen J, editor. Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988.
48. Curtin F, Schulz P. Multiple correlations and bonferroni's correction. Biol Psychiatry. 1998;44:775-7.
49. Altman D. Practical statistics for medical research. London: Chapman & Hall/CRC; 1991.
50. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310:170.
51. Willan A, Briggs AH. Statistical analysis of cost-effectiveness data. Chichester, West Sussex: John Wiley & Sons Ltd.; 2006.
52. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-94.
53. Glick H, Doshi J, Sonnad S, Polsky D. Economic evaluation in clinical trials. 2nd ed. Oxford, UK: Oxford University Press; 2015.
54. Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897-916.
55. Parkin D, Rice N, Devlin N. Statistical analysis of EQ-5D profiles: Does the use of value sets bias inference? Med Decis Mak. 2010;30:556-65.
56. Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res. 2014;23:977-89.
57. Steptoe A, Deaton A, Stone AA. Subjective wellbeing, health, and ageing. Lancet. 2015;385:640-8.
58. Parkin D, Devlin N, Feng Y. What determines the shape of an EQ-5D index distribution? Med Decis Making. 2016.
59. Canadian Agency for Drugs and Technologies in Health: Guidelines for the economic evaluation of health technologies: Canada. 3rd edn. Ottawa; 2006.
60. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.4). Canberra: Department of Health, Commonwealth of Australia; 2013.
61. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. NHS: UK; 2013.
62. Council HP. In: Council HP, editor. State of Our Health: Health Status and Health Determinants of South Australians Working Draft for Discussion. South Australia: Government of South Australia; 2013.
63. Brennan DS, Teusner DN. Comparing UK, USA and Australian values for EQ-5D as a health utility measure of oral health. Community Dent Health. 2015;32:180-4.
64. National Institute for Clinical Excellence. Guide to the methods of technology appraisal. London, UK: National Institute for Clinical Excellence; 2008.
65. Pullenayegum EM, Perampaladas K, Gaebel K, Doble B, Xie F. Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection? Eur J Health Econ. 2015;16:847-55.
66. Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy. 2013;11:287-98.